Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands

被引:32
作者
Bakalova, A
Buyukliev, R
Tcholakova, I
Momekov, G
Konstantinov, S
Karaivanova, M
机构
[1] Med Univ, Fac Pharm, Dept Chem, Sofia 1000, Bulgaria
[2] Med Univ, Fac Pharm, Dept Organ Chem, Sofia 1000, Bulgaria
[3] Med Univ, Fac Pharm, Dept Pharmacol & Toxicol, Sofia 1000, Bulgaria
[4] Univ Chem Technol & Met, Dept Inorgan Chem, Sofia 1756, Bulgaria
关键词
Pt(II) complexes; hydantoins; cytotoxicity; apoptosis;
D O I
10.1016/S0223-5234(03)00080-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interaction of cis-dichlorodiaminplatinum(II) (cis-DDP) with 2 4-imidazolidenedione-5-methyl-5-phenyl was studied. The method of preparation of the new Pt(II) complex consisted in precipitation of chloride ions from cis-DDP via a diaqua complex and reaction with the ligand in water-organic media. On the basis of IR spectra, H-1- and C-13-NMR analysis the coordination mode of the ligand and most fitting structures of two isomeric complexes were proposed. The pharmacological investigations revealed that the new Pt(11) complex with 5-methyl-5-phenylhydantoin (PtMPH) as well as the previously described Pt(II) complexes with cyclopentanespiro-5'-hydantoin and cyclohexanespiro-5'-hydantoin (PtCHH) exerted concentration-dependent cytotoxic effect in a panel of human tumor cell lines. On the basis of the IC50 values obtained PtMPH proved to be the most active cytotoxic agent. The other investigated complexes were less active, and among them PtCHH was the least potent antineoplastic agent. The pharmacodynamic investigation of PtMPH showed that this compound induces programmed cell death (apoptosis), as evidenced by the detection of oligonucleosomal DNA fragmentation in HL-60 cells after treatment with PtMPH. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:627 / 632
页数:6
相关论文
共 21 条
[1]  
ALBERTS DS, 1996, PLATINUM OTHER METAL, V2, P303
[2]   REDUCTION OF OSO4 BY SOME IMIDAZOLIDINE-2-THIONES - X-RAY CRYSTAL-STRUCTURE OF TRANS-DICHLOROTETRAKIS(NN'-DIETHYLIMIDAZOLIDINE-2-THIONE)-OSMIUM(IV) DIPERCHLORATE [J].
ANTOLINI, L ;
CRISTIANI, F ;
DEVILLANOVA, FA ;
DIAZ, A ;
VERANI, G .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1983, (07) :1261-1264
[3]   REACTIONS OF THIAZOLIDINE-2-THIONES WITH COPPER(II) [J].
BASSON, WD ;
PREEZ, ALD .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1974, (16) :1708-1711
[4]  
Cleare M. J., 1979, U.S. Patent Office, Patent No. [4,140,707, 4140707]
[5]   COPPER(I) COMPLEXES FROM CUX2(X=NO3, BF4, 1/2SO4) AND SOME HETEROCYCLIC LIGANDS CONTAINING THE THIOAMIDO GROUP [J].
DEVILLANOVA, FA ;
ISAIA, F ;
VERANI, G .
JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1981, 43 (11) :2749-2752
[6]   NICKEL(II) AND COBALT(II) COMPLEXES OF RHODANINE [J].
FABRETTI, AC ;
PEYRONEL, G .
TRANSITION METAL CHEMISTRY, 1977, 2 (05) :207-210
[7]   COPPER(I) COMPLEXES OF RHODANINE [J].
FABRETTI, AC ;
PEYRONEL, G ;
FRANCHINI, GC .
TRANSITION METAL CHEMISTRY, 1978, 3 (03) :125-127
[8]  
Henkels KM, 1999, CANCER RES, V59, P3077
[9]   NEW PLATINUM ANTITUMOR COMPLEXES [J].
KELLAND, LR .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1993, 15 (03) :191-219
[10]   Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance [J].
Kelland, LR ;
Sharp, SY ;
O'Neill, CF ;
Raynaud, FI ;
Beale, PJ ;
Judson, IR .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 77 (1-2) :111-115